Header Logo

Connection

CHARLES LU to Drug Carriers

Back to Details
This is a "connection" page, showing publications CHARLES LU has written about Drug Carriers.
CHARLES LU
Connection Strength
0.059
Drug Carriers
  1. Phase II study of a liposome-entrapped cisplatin analog (L-NDDP) administered intrapleurally and pathologic response rates in patients with malignant pleural mesothelioma. J Clin Oncol. 2005 May 20; 23(15):3495-501.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.